Related Experiment Video
Updated: Aug 31, 2025

09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
Melanoma risk during immunomodulating treatment
Yixuan James Zheng1,2, Wilson Ho1, Martina Sanlorenzo1,3,4
1Department of Dermatology, University of California San Francisco.
Melanoma Research
|August 22, 2022
Summary
Immunosuppressants are crucial for treating inflammatory diseases but increase cancer risk. For melanoma patients, avoid specific immunosuppressants like cyclosporine and methotrexate, and undergo regular skin checks.
Area of Science:
- Immunology
- Oncology
- Dermatology
Background:
- Immunosuppressive therapy is standard for inflammatory diseases and organ transplantation.
- Immunosuppressants are linked to an elevated risk of specific cancers, including melanoma.
- Melanoma, an immunogenic tumor, is significantly impacted by the immune system.
Approach:
- This literature review synthesizes the impact of common immunomodulating agents on melanoma.
- The review details drug mechanisms of action and their influence on melanoma development, recurrence, and progression.
Key Points:
- Cyclosporine, sirolimus, natalizumab, IL-6 inhibitors, cyclophosphamide, methotrexate, and TNF-alpha inhibitors (infliximab, etanercept) may promote melanoma.
- These agents should be avoided in patients with a history of invasive melanoma when possible.
Conclusions:
- Careful consideration of immunosuppressant use is vital in melanoma patients.
- Regular dermatological surveillance (every 6 months) is recommended for patients requiring these agents if no alternatives exist.
Related Concept Videos
Tumor Immunotherapy
644
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
644
Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cancer Vaccines
498
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
498
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
257
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
257

